These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16471901

  • 21. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of polyanion-resistance on HIV-1 infection.
    Bobardt MD, Armand-Ugón M, Clotet I, Zhang Z, David G, Este JA, Gallay PA.
    Virology; 2004 Aug 01; 325(2):389-98. PubMed ID: 15246277
    [Abstract] [Full Text] [Related]

  • 24. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
    Graf von Stosch A, von der Lieth CW, Reed J.
    Proteins; 1999 Feb 01; 34(2):197-205. PubMed ID: 10022355
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C, Klimkait T, Mahmood N, Pritchard M, Gilbert IH.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2673-6. PubMed ID: 15109676
    [Abstract] [Full Text] [Related]

  • 28. Specific CD4 down-modulating compounds with potent anti-HIV activity.
    Vermeire K, Schols D.
    J Leukoc Biol; 2003 Nov 17; 74(5):667-75. PubMed ID: 12960237
    [Abstract] [Full Text] [Related]

  • 29. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM, Kornoushenko YV, Kashyn IA, Kisel MA, Tuzikov AV.
    J Biomol Struct Dyn; 2015 Nov 17; 33(5):1051-66. PubMed ID: 24942968
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate.
    Baek WK, Jang BC, Lim JH, Kwon TK, Lee HY, Cho CH, Kim DK, Shin DH, Park JG, Lim JG, Bae JH, Bae JH, Yoo SK, Park WK, Song DK.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1560-7. PubMed ID: 16216226
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.
    Pan Y, Ma B, Nussinov R.
    J Mol Biol; 2005 Jul 15; 350(3):514-27. PubMed ID: 15946678
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
    Sharma SK, Kumar G, Kapoor M, Surolia A.
    Biochem Biophys Res Commun; 2008 Mar 28; 368(1):12-7. PubMed ID: 17996734
    [Abstract] [Full Text] [Related]

  • 38. Understanding of the bridging sheet formation of HIV-1 glycoprotein gp120.
    Da LT, Quan JM, Wu YD.
    J Phys Chem B; 2009 Oct 29; 113(43):14536-43. PubMed ID: 19813706
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.